ALS and fertility: does ALS affect number of children patients have?

HIlmi Uysal*, Uğur Bilge, Nevruz İlhanli, Marta Gromicho, Julian Grosskreutz, Magdalena Kuzma-Kozakiewicz, Susana Pinto, Susanne Petri, Katarzyna Szacka, Krzysztof Nieporecki, Mamede De Carvalho

*Corresponding author for this work

Abstract

Objective: Amyotrophic Lateral Sclerosis is one major disease in the group of neurodegenerative conditions. As with most other neurodegenerative diseases, clinical signs of the disease usually show among the elderly population, and most commonly around 60–65 years of age. Therefore the disease is not expected to impact the fertility of ALS patients. When examined from an evolutionary medicine and evolutionary biology perspective, there should be no selection pressure on the patient population due to the late onset of ALS. Methods: In this study, we tested the hypothesis that ALS does not affect fertility on a group of patients with ALS that we collected in a multi-center study. We recruited 511 patients diagnosed with ALS according to the revised El Escorial criteria, and 236 control cases without a neurodegenerative disease. We compared the ALS group’s number of offspring with the control group in three consecutive generations. Results: No statistically significant difference was found between the number of siblings of ALS and control groups (p = 0.44). A statistically significant difference was found between the number of children of ALS and control groups (p < 0.001), indicating ALS patients had more children than controls. When the number of children is assessed by gender, for women, there was no statistically significant difference between the number of children of ALS and control groups (p = 0.067). Conclusions: This finding supports the view that ALS does not have a negative selection pressure on the patient population’s fertility.

Original languageEnglish
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume22
Issue number1-2
Pages (from-to)94-100
Number of pages7
ISSN2167-8421
DOIs
Publication statusPublished - 2021

Funding

This study was supported by OnWebDuals project. This is an EU Joint Programme—Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organization under the aegis of JPND—www.jpnd.eu: Bundesministerium für Bildung und Forschung (BMBF), Germany; Narodowe Centrum Badań i Rozwoju [NCBiR; JNPD 01ED1511B; DZP/2/JPND-III/2015], Poland; Fundação a Ciência e a Tecnologia (FCT), Poland; Vetenskapsrådet (VR), Sweden. The authors thank Philippa Price for making the English revisions of the article in her native language.

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
  • Centers: Center for Neuromuscular Diseases

Cite this